Sonoma Pharmaceuticals Inc (SNOA)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current SNOA market cap is 6.63M. The company's latest EPS is USD -0.2575 and P/E is -1.40.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 3.01M | 3.43M | 2.73M | 3.14M | 3.44M |
| Operating Income | -1.15M | -1.24M | -1.21M | -844k | -1.41M |
| Net Income | -1.31M | -1.42M | -1.48M | -866k | -1.07M |
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 18.94M | 18.63M | 12.63M | 13.27M | 12.74M |
| Operating Income | -6.67M | -3.45M | -5.89M | -4.57M | -4.7M |
| Net Income | -2.95M | -3.95M | -5.09M | -5.15M | -4.84M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 16.23M | 15.89M | 13.64M | 14.62M | 14.74M |
| Total Liabilities | 8.25M | 8.65M | 7.96M | 7.93M | 8.6M |
| Total Equity | 7.98M | 7.24M | 5.68M | 6.69M | 6.14M |
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 14.56M | 14.99M | 18.85M | 16.23M | 14.74M |
| Total Liabilities | 5.86M | 9.62M | 10.15M | 8.25M | 8.6M |
| Total Equity | 8.71M | 5.36M | 8.7M | 7.98M | 6.14M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -6.15M | -215k | -1.45M | -2.55M | -2.4M |
| Investing | -258k | -17k | -19k | -20k | -2k |
| Financing | 2.49M | -135k | -264k | 1.05M | 1.68M |
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -4.54M | -3.38M | -4.25M | -6.15M | -2.4M |
| Investing | 3.59M | 388k | -99k | -258k | -2k |
| Financing | 1.03M | 3.31M | 7.4M | 2.49M | 1.68M |
| Market Cap | 6.63M |
| Price to Earnings Ratio | -1.40 |
| Price to Sales Ratio | 0.53 |
| Price to Cash Ratio | 2.16 |
| Price to Book Ratio | 1.1 |
| Dividend Yield | - |
| Shares Outstanding | 18.77M |
| Average Volume (1 week) | 2.21M |
| Average Volume (1 Month) | 4.48M |
| 52 Week Change | -69.30% |
| 52 Week High | 1.17 |
| 52 Week Low | 0.1159 |
| Spread (Intraday) | 0.02 (4.57%) |
| Company Name | Sonoma Pharmaceuticals Inc |
| Address |
850 new burton road dover, delaware 19904 |
| Website | https://www.sonomapharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
